by Canine influenza vaccines help in prevention of canine influenza virus (CIV), commonly known as dog flu, in dogs. CIV causes respiratory disease in dogs and its symptoms include coughing, sneezing, fever and lethargy. Increasing prevalence of dog flu outbreaks and rising awareness about importance of vaccination against infectious diseases in pets are driving demand for canine influenza vaccines.
The global canine influenza vaccine market is estimated to be valued at US$ 2,562.1 Mn in 2024 and is expected to exhibit a CAGR of 5.1% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Global Canine Influenza Vaccine Market Size are Zoetis Services LLC, Merck & Co., Inc., Covetrus, CSL Limited, Boehringer Ingelheim Animal Health USA Inc., and Elanco.
Increasing pet ownership and outbreaks of dog flu in previously unaffected regions have opened new opportunities for players in the canine influenza vaccine market. Moreover, advancements in vaccine technologies like recombinant vaccines are further enhancing efficacy of canine influenza vaccines.
Technological advancements like development of recombinant and intranasal canine influenza vaccines have made vaccination more effective and convenient. These new generation vaccines induce both mucosal and systemic immunity against CIV.
Market Drivers
Increasing awareness about importance of vaccination: Growing awareness among pet owners about benefits of vaccination in prevention of infectious diseases in dogs is a major driver for canine influenza vaccine market. Pet owners do not want to see their dogs suffering from deadly diseases.
Challenges in the Global Canine Influenza Vaccine Market
The Global Canine Influenza Vaccine Market is facing challenges such as lack of awareness regarding the disease and its preventive measures among pet owners. Canine influenza virus is highly contagious and spreads easily through direct contact among infected and susceptible dogs. However, many pet owners remain unaware about this disease and the need for vaccination, which poses a challenge for market players to raise awareness. Additionally, the cost of vaccination is also a barrier, as many pet owners in developing regions cannot afford the vaccines due to financial constraints.
SWOT Analysis
Strength: The vaccines available in the market are safe and effective at preventing the canine influenza virus. Regular vaccination helps curb the spread of the disease.
Weakness: High costs of research and development for new vaccines. Dependence on seasonal flu strains circulated among dogs.
Opportunity: Increasing pet adoption and growing awareness about pet healthcare management create demand for preventive vaccines. Rising incidence of Global Canine Influenza Vaccine Market outbreaks highlight the need for vaccination.
Threats: Threat from alternative prevention and treatment measures. Possible mutations in the virus strain challenge vaccine development.
The United States accounts for the major share of the global canine influenza vaccine market in terms of value, owing to high pet adoption and expenditure on pet healthcare. Additionally, increasing incidence of the disease in various regions drives vaccine usage. Europe is another key revenue generator due to growing awareness about pet health management.
Asia Pacific is projected to witness the fastest growth during the forecast period. This is attributed to rising pet population, improving healthcare infrastructure, and increasing per capita income in several emerging countries such as India and China. Heightened efforts by market players and veterinary bodies to educate pet owners regarding canine influenza prevention measures also boost regional market prospects.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
